Page 22 - Usfda

Wockhardt gets USFDA nod for generic eye drops

The product will be manufactured at a USFDA approved contract manufacturing organisation

USFDA scrutiny of Indian pharma units up three-fold in 6 years

This has led to rise in warnings too; 55% of GMP warnings since 2012 issued to Indian, Chinese cos

US FDA sounds alert on quality issues in Indian pharma

Warning letters might increase as 190 facilities are expected to be inspected in the next 3 years

USFDA inspects Cadila Healthcare's Moraiya facility

The FDA Form 483 notifies the company's management of objectionable conditions

USFDA warns Resonance Labs of manufacturing norms violations

Violations include failure to have adequate cleaning procedures to prevent contamination of products

Would Washington's FDA Fix Cure the Patients or the Drug Industry?

A bill that would speed up approval for medications and medical devices shows how a major initiative can get traction

India seeks inputs from 200 countries for amending drugs and cosmetics act

Drug controller is rest assured that only recommendations will be taken and the will ensure that laws do not harm the medium and small players in India

Natco Pharma gets EIR from USFDA for Chennai facility

USFDA released a copy of EIR to the establishment that was the subject of an FDA or FDA-contracted inspection when agency determines the inspection to be closed

Orchid gets final nod from USFDA for Parkinson's drug

Orchid Pharma stock was trading up 12.18% at Rs 41.90 during the afternoon trade on BSE

More inspections due to rising drug imports from India: USFDA

The federal agency had taken action against companies like Sun Pharma last year & earlier Ranbaxy among other Indian drug companies.